BioTech/Drugs - Lawrence, KS, us
Kanpecia is developing a topically applied alopecia medication, KaB-103, and is focused on both Chemotherapy Induced Alopecia (CIA) and the multibillion-dollar Androgenic Alopecia market.
Gmail
Apache
WordPress.org
Mobile Friendly